Article Figures & Data
Tables
- Table 1:
Estimated prevalence for extraspinal findings, patients, and clinically significant findings
Groups Studies Total Events Proportion (95% CI) I2 (%)a All extraspinal findings Overall 168-23 19593 6006 19.93 (11.05–30.65) 99.7 Men 310,12,15 4344 1463 33.28 (24.50–42.69) 97.7 Women 310,12,15 5692 2722 55.05 (12.72–93.22) 99.9 Men and women (<40 years) 119 269 5 1.86 (0.61–4.28) – Men and women (≥40 years) 411,19,21,23 1261 150 13.81 (0.80–37.82) 98.9 All patients with extraspinal findings Overall 108-13,15,19,22,23 14992 5215 26.65 (14.76–40.57) 99.7 Men 38,10,12 2934 902 24.34 (11.03–40.81) 98.7 Women 38,10,12 3490 1919 51.04 (2.91–97.76) 99.9 Men and women (<40 years) 212,19 540 55 8.29 (6.09–10.79) – Men and women (≥40 years) 411,12,19,23 3961 785 16.23 (4.78–32.67) 99.0 All clinically significant findings Overall 810-13,15,18,22,23 12778 901 5.35 (3.15–8.08) 97.1 Men 310,12,15 4344 260 5.92 (4.61–7.39) 74.2 Women 310,12,15 5692 533 9.77 (4.67–16.48) 98.3 Men and women (≥40 years) 211,23 672 67 9.96 (7.80–12.36) – Note:— Subgroups not stated if no studies reported data for such.
↵a I2 not estimable for some individual subgroups and marked as en dash.
Body Regions Studies Total Events Proportion (95% CI) I2 (%)a Gastrointestinal Overall 128,10-18,20,21 16592 929 2.04 (0.29–5.22) 99.2 Men 210,15 2993 254 6.90 (6.02–7.84) – Women 210,15 4019 460 8.15 (7.33–9.02) – Men and women (≥40 years) 211,21 330 8 2.31 (0.82–4.38) – Genitourinary Overall 148,10-22 17689 2631 8.74 (4.73–13.81) 99.1 Men 210,15 2993 814 27.14 (25.56–28.75) – Women 210,15 4019 725 17.49 (16.33–18.68) – Men and women (<40 years) 119 269 0 0.19 (0.00–0.56) – Men and women (≥40 years) 311,19,21 866 82 8.93 (0.00–35.57) 98.7 Gynecologic Women 38,10,15 4289 1004 24.03 (9.44–42.70) 99.3 Vascular Overall 138,10-18,20,22,23 16941 296 1.41 (0.73–2.30) 94.0 Men 210,15 2993 55 1.79 (1.34–2.30) – Women 210,15 4019 60 1.42 (1.08–1.82) – Men and women (≥40 years) 211,23 672 53 7.76 (5.84–9.92) – Musculoskeletal Overall 88,12,14-17,20,21 11537 54 0.52 (0.13–1.14) 91.1 Men 115 1540 5 0.32 (0.11–0.76) – Women 115 2472 6 0.24 (0.09–0.53) – Metastases Overall 78,14-17,20,21 8513 20 0.28 (0.01–0.77) 86.9 Men 115 1540 0 0.03 (0.00–0.53) – Women 115 2472 1 0.04 (0.00–0.23) – Miscellaneous Overall 712,14-17,20,21 11137 6 0.05 (0.00–0.13) 21.6 Men 115 1540 0 0.03 (0.00–0.53) – Women 115 2472 0 0.02 (0.00–0.52) – Note:— Subgroups not stated if no studies reported data for such.
↵a I2 not estimable for some individual subgroups and marked as en dash.